Literature DB >> 19433973

The MALAdy of metformin poisoning: Is CVVH the cure?

Anna Maria Arroyo1, Todd A Walroth, James B Mowry, Louise W Kao.   

Abstract

Inadvertent or intentional metformin overdose can result in death from refractory lactic acidosis. We report a death from metformin-induced refractory lactic acidosis despite aggressive care. A 49-year-old hypertensive diabetic female presented 1 hour after ingesting 60 tablets of 500 mg metformin and 20 combination tablets of 12.5 mg hydrochlorothiazide/20 mg lisinopril. She was awake and alert, with a blood glucose of 579 mg/dL. Chemistry panel revealed lactic acidosis and acute renal failure (arterial blood gas pH, 7.18; pCO(2), 15 mm Hg; pO(2), 127 mm Hg; HCO(3), 6 mmol/L; lactate, 9.6 mmol/L; and creatinine, 1.2 mg/dL [0.8 mg/dL previously]). She received normal saline, sodium bicarbonate, and insulin. On arrival to the intensive care unit she was obtunded, with a blood pressure of 40/25 mm Hg and had worsening acidosis and poor oxygenation (arterial blood gas pH, 6.79; pCO(2), 55; pO(2), 57; HCO(3), 8.4; and base excess of -25 on 100% fractional inspired oxygen). She was intubated and received additional fluid boluses, bicarbonate, and norepinephrine. Continuous veno-venous hemofiltration (CVVH) was started 6 hours after her ingestion. Metformin was 380 microg/mL on CVVH initiation. The patient developed pulseless electrical activity 30 hours after her ingestion, which recurred 20 minutes later. The family requested no further resuscitation. She died 31.5 hours after her ingestion. Metformin concentrations decreased to 97 microg/mL 28 hours after the ingestion on CVVH, with a first-order elimination half-life of 11.3 hours (r(2) = 0.99) and a clearance of 56.2 mL/min. Further investigations on the place of CVVH in the management of the poisoned patient with MALA unable to hemodynamically tolerate conventional hemodialysis may be needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19433973     DOI: 10.1097/MJT.0b013e318197eab6

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  7 in total

1.  Fatal metformin overdose: case report and postmortem biochemistry contribution.

Authors:  Alessandro Bonsignore; Fulvia Pozzi; Giulio Fraternali Orcioni; Francesco Ventura; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2013-11-08       Impact factor: 2.686

2.  Metformin-related lactic acidosis in patients with acute kidney injury.

Authors:  Vassilios Devetzis; Ploumis Passadakis; Stelios Panagoutsos; Marios Theodoridis; Elias Thodis; Anastasia Georgoulidou; Vassilis Vargemezis
Journal:  Int Urol Nephrol       Date:  2010-09-22       Impact factor: 2.370

3.  Management of metformin-associated lactic acidosis by continuous renal replacement therapy.

Authors:  Geoffray Keller; Martin Cour; Romain Hernu; Julien Illinger; Dominique Robert; Laurent Argaud
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

4.  Toxicokinetics of Metformin During Hemodialysis.

Authors:  Paul Ayoub; Pierre-Olivier Hétu; Monique Cormier; Alexandre Benoit; Andrea Palumbo; Marie-Claude Dubé; Sophie Gosselin; Marc Ghannoum
Journal:  Kidney Int Rep       Date:  2017-03-07

5.  A case of type 2 diabetes mellitus with metformin-associated lactic acidosis initially presenting the appearance of a sulfonylurea-related hypoglycemic attack.

Authors:  Kota Nishihama; Kanako Maki; Yuko Okano; Rei Hashimoto; Yasuhiro Hotta; Mei Uemura; Taro Yasuma; Toshinari Suzuki; Toyomi Hayashi; Eiji Ishikawa; Yutaka Yano; Esteban C Gabazza; Masaaki Ito; Yoshiyuki Takei
Journal:  Acute Med Surg       Date:  2016-08-03

6.  Metformin-associated lactic acidosis: reinforcing learning points.

Authors:  Mohummad Shaan Goonoo; Rebecca Morris; Ajay Raithatha; Fionuala Creagh
Journal:  BMJ Case Rep       Date:  2020-09-02

7.  Metformin-Associated Lactic Acidosis following Intentional Overdose Successfully Treated with Tris-Hydroxymethyl Aminomethane and Renal Replacement Therapy.

Authors:  Ngan Lam; Gurbir Sekhon; Andrew A House
Journal:  Case Rep Nephrol       Date:  2012-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.